You are here: vision-research.eu » People » Research Groups » United Kingdom » Scanlon, Peter

Gloucestershire Diabetic Retinopathy Research Group

This research group aims to reduce the risk of sight loss among people with diabetes by the prompt Identification and effective treatment of sight threatening retinopathy. Identification involves systematic screening using digital photography and image grading to view and monitor changes occurring within the retina. Treatment might involve the application of lasers and/or different drug regimes.

Methodology

Studies involve a combination of patient questionnaires and  interviews, data collection / extraction and statistical analysis, patient information transfer and collation, and clinical trials.

Scientific Cooperations

  • Cooperation 1:
    University of Warwick
  • Cooperation 2:
    University of Oxford
  • Cooperation 3:
    European Network of Clinical Research in Ophthalmology
  • Cooperation 4:
    Royal College of Ophthalmologists
  • Cooperation 5:
    Pfizer Ltd.

Group Leader

Peter Scanlon
[more information]

Contact

Gloucestershire Hospitals NHS Foundation Trust

Cheltenham General Hospital

Sandford Road
GL53 7AN
Cheltenham, Gloucestershire
United Kingdom

Phone: (44) 08454 222 851
Fax: (44) 08454 223 853

E-mail:
peter.scanlon[at]glos.nhs.uk

Current Research Projects

  • Project 1
    FLURRI - Understanding factors leading to low uptake of diabetic retinopathy screening in primary care.
  • Project 2
    Development of a cost-effectiveness model for optimization of the screening interval in diabetic retinopathy screening.
  • Project 3
    EUROCONDOR – European Consortium for the early treatment of diabetic retinopathy using eye drops of neuroprotective drugs.
  • Project 4
    GP2DRS – General practice to diabetic retinopathy screening programme information transfer system development.
  • Project 5
    NOD – National Ophthalmology Database development.

Research Groups

People

Related Research Groups

clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology
Oops, an error occurred! Code: 201908170342151ea3ca20
clinical (human) or epidemiologic studies: health care delivery/economics/manpower
Oops, an error occurred! Code: 20190817034215bcee5d1c
clinical (human) or epidemiologic studies: prevalence/incidence
Oops, an error occurred! Code: 201908170342155c53fd93
clinical (human) or epidemiologic studies: risk factor assessment
Oops, an error occurred! Code: 2019081703421523c58809
clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials
Oops, an error occurred! Code: 20190817034215900745a0
diabetic retinopathy
Oops, an error occurred! Code: 20190817034215f59ac2eb
imaging/image analysis: clinical
Oops, an error occurred! Code: 20190817034215977af6ad
macula/fovea
Oops, an error occurred! Code: 2019081703421508c6a349
neuroprotection
Oops, an error occurred! Code: 201908170342154ca8660c
retinal neovascularization
Oops, an error occurred! Code: 201908170342158d2a1838
eye screening
Oops, an error occurred! Code: 2019081703421515308427
laser treatment
Oops, an error occurred! Code: 20190817034215d11c7d0d
medical retina
Oops, an error occurred! Code: 2019081703421566f8ccf6
screening epidemiology
Oops, an error occurred! Code: 201908170342150eedb1e5